FOXA1 and breast carcinoma: While the role of FOXA1 in resistance to traditional chemotherapy has not been explored in breast cancer, FOXA1 drives cell cycle progression in chondrosarcoma, a malignant bone tumor highly resistant to chemotherapy [38].